课题基金 / 基金详情

MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION

MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
心脏同种异体移植排斥的分子/细胞基础
批准号:
2068638
负责人:
Haval Shirwan
金额:
$11.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1999-04-30

项目摘要

项目成果

Haval Shirwan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objectives of this research proposal are to identify the molecular components of the immune recognition process involved in allograft rejection. Graft rejection is initiated by T cells of the recipient recognizing antigens of the foreign graft through clonally- expressed TCRs. The basis of this recognition process is the formation of a trimolecular complex consisting of the TCR, MHC molecule (of the recipient and/or donor type), and a peptide derived from metabolically processed graft antigens. The formation of this complex during immune response to the graft initiates a set of intra- and intercellular reactions that result in destruction of the graft. Hence, elucidation of the nature of the trimolecular complex and the subsequent events involved in the graft rejection will not only broaden our understanding of the rejection process, but may also provide a means to induce graft- specific tolerance. The Specific Aims of this proposal include: 1. Characterization of the TCR repertoire usage by GILs isolated from cardiac allografts performed in rat strain combinations disparate for range of histocompatibility antigens. 2. Establishment of T-cell lines and/or clones from GILs with specific reactivity to graft antigens and examination of their role in mediating cardiac graft rejection following adoptive transfer. 3. Identification of graft antigens that serve as targets for graft- reactive T cells and the analysis of their role in the rejection reaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel immunomodulatory approach to overcome innate and adaptiveimmune barriers to islet transplantation
  • 批准号:
    10289717
  • 项目类别:
  • 资助金额:
    $39.43万
  • 财政年份:
    2018
  • 负责人:
    Haval Shirwan
  • 依托单位:
Developing a novel adjuvant system for therapeutic vaccines against lung cancer
  • 批准号:
    9138899
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2016
  • 负责人:
    Haval Shirwan
  • 依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
  • 批准号:
    9066573
  • 项目类别:
  • 资助金额:
    $18.75万
  • 财政年份:
    2015
  • 负责人:
    Haval Shirwan
  • 依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
  • 批准号:
    8966928
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2015
  • 负责人:
    Haval Shirwan
  • 依托单位:
海外基金